The effect of temperature on the potencies of neuromuscular blocking agents remains unclear. This study was undertaken to examine the effects of different neuromuscular blocking agents at 37 and 27 °C at a constant carbon dioxide content (a stat principle). The effect of neostigmine 1 umol litre" 1 induced antagonism of these agents was also investigated. Phrenic nerve-hemidiaphragm preparations of rats were mounted in modified Krebs solution, maintained at 37 C C and aerated with a 5% carbon dioxide-95% oxygen gas mixture, and at 27 °C with 4% carbon dioxide to maintain the carbon dioxide content of the solution constant. Phrenic nerves were stimulated with 0.1 -Hz supramaximal impulses of 0.2-ms duration and the elicited tension of the diaphragm recorded. The potencies of the steroidal neuromuscular blocking agents (rocuronium, vecuronium, pancuronium and pipecuronium) increased significantly at 27 °C (P<0.05), while the potencies of the benzylisoquinolinium agents (tubocurarine and dimethyltubocurarine) did not change. Neostigmineinduced antagonism of the steroidal agents did not differ significantly between each other but differed significantly from the benzylisoquinolinium agents (P < 0.05) at both temperatures. The ratios of ICBO (inhibitory concentration, 50%) with and without neostigmine at hypothermia were slightly higher for the steroidal agents, indicating slight enhancement of antagonism by neostigmine at 27 °C. In contrast, the ratios were significantly greater at 27 °C (P < 0.05) for isoquinolinium agents, implying significant enhancement of antagonism. Our results indicate that at 27 °C the potency of all steroidal agents increased and neostigmine-induced antagonism was slightly enhanced. With the isoquinolinium agents, hypothermia caused no change in potency although neostigmine-induced antagonism was enhanced significantly. These findings suggest that the relative effects of steroidal and isoquinolinium agents on the neuromuscular junction are different or that they have a different mechanism of action on the neuromuscular junction. (Br. J. Anaesth. 1994; 73: 662-666) 
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The effect of temperature on the action of neuromuscular blocking agents remains unclear. Bigland and colleagues [1] and Cannard and Zaimis [2] reported that the competitive agents are more potent at 37 °C than at 27 °C. In contrast, Miller and coworkers [3, 4] reported an increase in potency at 27 °C in cats with tubocurarine and pancuronium. Farrell and colleagues [5] confirmed their findings with tubocurarine and pancuronium with constant partial pressure of carbon dioxide. Horrow and Bartkowski [6] reported that pancuronium is potent at 27 °C whereas tubocurarine, dimethyltubocurarine and gallamine are less potent at 27 °C. In all the above experiments only Farrell and colleagues described carbon dioxide management [5] -
We performed the present study on six neuromuscular blocking agents (rocuronium, vecuronium, pipecuronium, pancuronium, tubocurarine and dimethyltubocurarine) to observe their pharmacodynamic effects at 37 and 27 °C. In addition, we studied the influence of hypothermia on antagonism of the neuromuscular blocking agents by neostigmine. The experiment was performed following the principle of a stat management of Rahn, Reeves and Howell [7] that is maintaining the carbon dioxide content of the solution constant. This in vitro condition was chosen to maintain a constant condition of unchanging pharmacodynamics and pharmacokinetics.
Materials and methods
Experiments were carried out using rat phrenic nerve-hemidiaphragm preparations in accordance with the institutional animal care committee standards [8] . Male Sprague-Dawley rats weighing 250-300 g were decapitated and the hemidiaphragms accompanied by the phrenic nerves were dissected. The hemidiaphragm-phrenic nerve preparation was mounted in a double-walled glass organ bath of 100 ml capacity, filled with modified Krebs solution (mmol litre-1 ): NaCl 113.0; KC1 4.7; CaCl 2 1.4; KH 2 PO 4 1.2;MgSO 4 1.2;NaHCO 3 25.0; glucose 1.5 [9] . The costal end of the diaphragm was fixed with metal hooks to the bottom of the organ bath and the tendon was attached to a force displacement transducer (TB-611 T, Nihon Kohden Co, Tokyo, Japan) above the organ bath. The temperature of the solution of the bath was maintained by circulating water from a thermostatically controlled water bath and aerated with a 95 % oxygen and 5 % carbon dioxide gas mixture for 37 °C via a needle at the bottom. For experiments at 27 °C the composition of the bubbling gas mixture was changed to 96% oxygen and 4% carbon dioxide (carbon dioxide solubility increases at lower temperature), to maintain a constant concentration of carbon dioxide of the solution. The whole procedure from the start of the preparation to mounting was carried out at a temperature of 37 or 27 °C. All organ baths were covered with a lid to minimize temperature changes and atmospheric interferences. The concentration of the gases was controlled by flowmeters (Shimadzu 1203, Kyoto, Japan). The carbon dioxide concentration of the solution was measured by a blood-gas analyser (ABL 505 Radiometer, Copenhagen, Denmark). Supramaximal square wave impulses of 0.1 Hz and 0.2-ms duration were applied to die phrenic nerves, and the elicited twitch tensions of the diaphragm were recorded continuously. Optimal pretension was determined by gradually increasing die resting tension until further stretching of the preparation did not cause any additional increase in tension output. The twitch tension was dien stabilized at the temperature concerned for about 60 min. After that the following sets of experiments were performed.
First, we determined the effect of temperature on the potencies of the neuromuscular blocking agents. The doses of each drug were calculated and prepared to produce about 20%, 40%, 60% and 80% block, respectively, for each bath containing 100 ml of Krebs solution. These preselected doses of each drug at each temperature were added to the baths. For each dose of drug, five different preparations were used to obtain five data points. Thus for four doses of drug, 20 different preparations were used to obtain 20 data points; one experiment to determine a regression line using a least squares method consisted of 20 data points from 20 preparations. One experiment was performed for each drug at each temperature. To exclude the influence of fatigue and that of previously administered drug, each preparation was used only once. Thus log percent response regression lines for all neuromuscular blocking agents (rocuronium, vecuronium, pipecuronium, pancuronium, tubocurarine and dimethyltubocurarine) were constructed at both temperatures.
Second, to determine the effect of neostigmineinduced antagonism of the neuromuscular block at different temperatures, the drug and neostigmine 1 umol litre" 1 were given together and the log concentration-percent response lines were constructed in the same way as without neostigmine. These experiments were performed in a separate set of muscle preparations.
After obtaining data for the neuromuscular blocking agents, wash out was performed and the twitch height allowed to return to control height.
The IQo (inhibitory concentration, 50%) values of each drug with and without neostigmine at both temperatures were calculated from the concentration-response lines. Statistical analyses were performed to evaluate die slopes of the lines for each drug at the two temperatures (37 vs 27 °C) with and without neostigmine using ANOVA followed by Duncan's multiple range test [10] . The relative potency ratio of each drug at different temperatures with and without neostigmine was determined by the method of Tallarida and Murray (relative potency II: statistical analyses, graded data) [10] and then compared. Comparisons were made statistically using ANOVA followed by Duncan's multiple range test. In each case, differences were considered statistically significant if P < 0.05.
Results
With 5% carbon dioxide in the bubbling gas, die mean partial pressure of carbon dioxide in the solution measured at 37 °C was found to be 5.2 (SEM 0.02) kPa (n = 10) while at 27 °C the partial pressure was 5.3 (0.03) kPa (measured at 37 °C, n = 10) when the carbon dioxide concentration of the bubbling gas was reduced to 4 %.
The log concentration-percent response lines of all neuromuscular blocking agents investigated are shown in figure 1A and B. The lines for each drug were parallel and there were no significant differences in the slope values at die two temperatures (data not shown). For the steroidal neuromuscular blocking agents (rocuronium, vecuronium, pipecuronium and pancuronium, fig. 1 A) at 27 °C the lines were shifted towards die left from die lines at 37 °C, indicating increase in potency at lower temperature. In contrast, die lines at 27 °C were shifted towards the right from the lines at 37 °C for the benzylisoquinolinium neuromuscular blocking agents (tubocurarine and dimethyl tubocurarine, fig.  1 B) although this shift was not significant, indicating no change in potency at lower temperature.
The ICso values of all neuromuscular blocking agents are summarized in table 1. It may be seen diat the ICso values of the steroidal neuromuscular blocking agents at 27 °C were significantly lower than the ICJO values at 37 °C. This indicates that the potencies of steroidal agents were increased at lower temperature. In contrast, die ICJO values are not significantly different at the two temperatures for die benzylisoquinolinium neuromuscular blocking agents.
In the second part of this study, we investigated the effects of neostigmine-induced antagonism at hypothermia. The log concentration-percent response lines of all neuromuscular blocking agents were shifted to die right ( fig. 1 ) in the presence of neostigmine at both temperatures. The lines were parallel for each drug at both temperatures with neostigmine. The ratios of die IQo values for all agents with and without neostigmine at 37 and 27 °C are summarized in table 2. The ratios of the IQJO values of the drugs with and without neostigmine were studied as the value of the ratio indicates the amount of antagonism. When the ratio is greater, antagonism is also greater. For the steroidal agents the ratios of the ICJO values were not significantly different between each other, either at 37 or 27 °C, and also were not significantly different between the two temperatures, although the ratios increased to approximately 20-30 % (ns) at 27 °C compared with 37 °C. The ratios of the IC W values of the steroidal agents at both temperatures were significantly different from the benzylisoquinolinium agents. Also the ratios of the IQo values of tubocurarine and dimethyltubocurarine at 27 °C were significantly greater (70-80 %) than the values at 37 °C, implying significant enhancement of neostigmine-induced antagonism at hypothermia. This implies that hypothermia affected neostigmine-induced antagonism of the steroidal and benzylisoquinolinium agents differently and the enhancement was significant for the isoquinolinium agents.
Discussion
In the first part of this study, we found that the potencies of the steroidal neuromuscular blocking agents (rocuronium, pipecuronium, vecuronium and pancuronium) increased significantly at hypothermia (27 °C) while the potencies of the benzylisoquinolinium neuromuscular blocking agents (tubocurarine and dimethyltubocurarine) did not differ significantly. In a previous study, Holmes, Jenden and Taylor [11] demonstrated in rat diaphragm an increase in EC50 for tubocurarine at 25 °C. Bigland and colleagues [1] in cats and dogs and Cannard and Zaimis [2] in isolated limb of human, also reported that at hypothermia the potency of tubocurarine decreased. Miller and others [3, 4] and Farrell and colleagues [5] reported in cats augmentation of the potency of tubocurarine and pancuronium at hypothermia. Horrow and Barthowski [6] showed that pancuronium was more potent at 27 °C but tubocurarine and dimethyltubocurarine were less potent.
Miller and colleagues [3, 4] performed in vivo experiments with continuous infusion of neuromuscular blocking agents to produce a constant 90 % block. The change in the infusion rate of the agents required at different temperatures to maintain 90 % block was studied. Then they added neostigmine at this pre-existing block at different temperatures and studied the dose needed to produce 50% antagonism. They did not construct dose-response curves for the neuromuscular blocking agents to calculate the EDSQ or the potency of the neuromuscular blocking agents. In view of the relationship between the concentration of neuromuscular blocking agents and neuromuscular block (the sigmoid shaped doseresponse curve), observations at 90% block might not be sensitive enough [12] . These differing results may reflect different experimental conditions and techniques, species differences and carbon dioxide management at hypothermia. In in vivo and in vitro conditions, single or continuous administration of drug may change the results. Individual variations may also cause different results [13] .
In all the above studies, carbon dioxide management was not described, except by Farrell and colleagues [5] . They used a constant concentration of 5 % carbon dioxide. Carbon dioxide management is important as the temperature effect may be modified by the pH effect. In particular, when 5% carbon dioxide is bubbled through Krebs solution at the temperature tested, changes in carbon dioxide solubility with temperature make the resultant bath more acid at lower temperatures [14] . As the potency of tubocurarine is increased at lower pH [12] , any decrease in tubocurarine potency caused by hypothermia may be counteracted [14] . In the study of Cannard and Zaimis [2] , who used an isolated limb, dissolved carbon dioxide content in blood might have been constant.
There are two methods of carbon dioxide management during temperature changes, namely a stat and pH stat. a Stat management is achieved by maintaining the carbon dioxide content constant. Net protein charge states (termed a) are kept constant as temperature changes. pH stat management implies that pH is kept constant at a given temperature. Probably the a stat is more physiological but there is no definite consensus [15] . In hypothermic experiments, carbon dioxide management must be described as pH affects the potencies of monoquaternary neuromuscular blockers [12] . a Stat regulation is most easily implemented clinically by maintaining normal levels of pH at 7.4 and Pco 2 at 5.3 kPa, respectively, measured at 37 °C [15] . In our experiments we used the a stat principle [7] .
The changes produced by hypothermia may be caused by sluggish muscle membrane depolarization, diminished cholinesterase activity, increased acetylcholine release or decreased receptor affinity [16] . A change in the structural conformity of the drug at lower temperature should also be considered as this may affect receptor affinity. The reason for these difference is not clear. Possible explanations include: (a) presynaptic causes, as tubocurarine has some presynaptic mode of action [17, 18] . Bowman and Webb [19] also described the presynaptic effects of tubocurarine and the postsynaptic effects of pancuronium after studying the comparative effects of cholinergic antagonists on the tetanic fade of transmission ; (b) different affinity for the acetylcholine receptor subunits of the postjunctional membrane [20] ; and (c) anticholinesterase activities of the neuromuscular blocking agents. Beami, Bianchi and Ledda [21] reported that at 28 °C, tubocurarine produced 50 % reduction in acetylcholine output.
For the second part of this study, neostigmineinduced antagonism of the neuromuscular blocking agents was observed at two temperatures. It was found that antagonism did not increase if the concentration of neostigmine was increased above 1 umol litre" 1 [unpublished data] and therefore this supramaximal concentration of neostigmine was used (1 umol litre" 1 ) in our studies. Bartkowski [22] also showed a ceiling effect for neostigmine in rat phrenic nerve-diaphragm preparations. When the ratios of IC^ with and without neostigmine were considered, it was found that neostigmine-induced antagonism was slightly enhanced (20-30 %) at 27 °C for steroidal agents (table 2). The ratios of the IC^o values at each temperature did not differ significantly between the steroidal agents but the ratios of these agents differed significantly from those of the benzylisoquinolinium agents at each temperature. When the ratios of the IC50 values of tubocurarine and dimethyltubocurarine were compared at the two temperatures, it was found out that the ratios were significantly higher (70-80%) at 27 °C, indicating that neostigmine-induced antagonism was enhanced significantly at hypothermia. The exact cause is not clear, but it may be suggested that the relative contribution of effects of the steroidal and benzylisoquinolinium neuromuscular blocking agents at the neuromuscular junction differ. Tubocurarine has some presynaptic effects [19] and anticholinesterase effects at hypothermia [21] which contribute to the action of neostigmine. Neostigmine also has presynaptic effects [23, 24] in addition to its anticholinesterase effects.
Our results differ from those of Miller and colleagues [3, 4] who showed that the magnitude of neostigmine-induced antagonism of tubocurarine [3] and pancuronium [4] did not change at hypothermia. They added neostigmine after partial block was produced by the neuromuscular blocking agents and then studied the dose of neostigmine required to produce 50% antagonism. In our study we added the agents and neostigmine together and constructed the log concentration-percent response lines and compared those with control. As they studied the effect of temperature on pre-existing block, the temperature-induced changes in muscle contraction itself might have affected their results. The changes in pharmacokinetics in vivo also have to be considered. Therefore, the results of Miller and colleagues may differ from ours because of in vivo as opposed to in vitro conditions, species differences and the experimental design.
